Advanced search
Publication Cover
Scandinavian Journal of Rheumatology Volume 49, 2020 - Issue 1
Submit an article Journal homepage
261
Views
9
CrossRef citations to date
0
Altmetric
Letters

New onset of psoriasis induced by secukinumab in a patient with ankylosing spondylitis: a case report

D CurradoUnit of Allergology, Immunology, Rheumatology, Department of Medicine, Campus Bio-Medico University of Rome, Rome, ItalyCorrespondence[email protected]
,
DPE MargiottaUnit of Allergology, Immunology, Rheumatology, Department of Medicine, Campus Bio-Medico University of Rome, Rome, Italy
,
C ConfortiDermatology Clinic, Maggiore Hospital, University of Trieste, Trieste, Italy
,
R CoppolaUnit of Plastic and Reconstructive Surgery, Sapienza University, Rome, Italy;Unit of Plastic and Reconstructive Surgery, Department of Medicine, Campus Bio-Medico University of Rome, Rome, Italy
,
V PanasitiUnit of Plastic and Reconstructive Surgery, Department of Medicine, Campus Bio-Medico University of Rome, Rome, Italy
,
A AfeltraUnit of Allergology, Immunology, Rheumatology, Department of Medicine, Campus Bio-Medico University of Rome, Rome, Italy
&
L NavariniUnit of Allergology, Immunology, Rheumatology, Department of Medicine, Campus Bio-Medico University of Rome, Rome, Italy
 show all
Pages 75-76 | Accepted 09 Mar 2019, Published online: 02 Jul 2019

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Francesco Messina & Stefano Piaserico. (2022) The dark side of the moon: the immune-mediated adverse events of IL-17A/IL-17R inhibition. Journal of Dermatological Treatment 33:5, pages 2443-2454.
Read now

Articles from other publishers (8)

Yachen Wang, Fengling Yang, Ruizhe Wang & Suju Luo. (2024) Paradoxical psoriasis induced by IL-17 antagonists. Indian Journal of Dermatology, Venereology and Leprology 0, pages 1-9.
Crossref
Khalid A Alnaqbi, Jawaher Al Zeyoudi, Fahad Fazal, Omar M Alhaj, Imad Jassim & Fatima A Albreiki. (2023) Paradoxical Psoriasis and Worsening Spondylitis Due to Secukinumab in a Patient With Ankylosing Spondylitis: A Case Report and Literature Review. Cureus.
Crossref
Vishnu Eshwar, Ashwin Kamath, Rajeshwari Shastry, Ashok K. Shenoy & Priyanka Kamath. (2022) A Review of the Safety of Interleukin-17A Inhibitor Secukinumab. Pharmaceuticals 15:11, pages 1365.
Crossref
Jingyao Liang, Sanquan Zhang, Qian Li, Yihui Yu, Xiaoyin Chen & Xibao Zhang. (2022) Review of secukinumab‐induced adverse events of special interest and its potential pathogenesis. Dermatologic Therapy 35:8.
Crossref
Michael J. Murphy, Jeffrey M. Cohen, Matthew D. Vesely & William Damsky. (2022) Paradoxical eruptions to targeted therapies in dermatology: A systematic review and analysis. Journal of the American Academy of Dermatology 86:5, pages 1080-1091.
Crossref
Joanna Golińska, Marta Sar-Pomian & Lidia Rudnicka. (2022) Diagnostic Accuracy of Trichoscopy in Inflammatory Scalp Diseases: A Systematic Review. Dermatology 238:3, pages 412-421.
Crossref
Adrian Ciurea & Raphael Micheroli. (2020) Response to: ‘Correspondence on ‘Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohort’ by Micheroli et al’ by Huang et al . Annals of the Rheumatic Diseases, pages annrheumdis-2020-218832.
Crossref
Claudio Conforti, Chiara Retrosi, Roberta Giuffrida, Roberta Vezzoni, Damiano Currado, Luca Navarini, Eleonora Farinazzo, Carmen Dell'Aquila, Katiuscia Nan, Nicola Di Meo & Iris Zalaudek. (2020) Secukinumab‐induced subacute cutaneous lupus erythematosus. Dermatologic Therapy 33:3.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.